Immunic, Inc. Public Float
Immunic, Inc. (IMUX) had Public Float of $83.10 million as of 2025-06-30, per its 10-K/A filed 2026-04-22.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-22
- 2025-06-30: Entity Public Float $83.10M.
- 2024-06-30: Entity Public Float $100.00M.
- 2023-06-30: Entity Public Float $109.50M.
- 2022-06-30: Entity Public Float $106.10M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $83.10M 10-K/A · filed 2026-04-22 |
| 2024-06-30 | $100.00M 10-K · filed 2025-03-31 |
| 2023-06-30 | $109.50M 10-K · filed 2024-02-22 |
| 2022-06-30 | $106.10M 10-K · filed 2023-02-23 |
| 2021-06-30 | $225.00M 10-K · filed 2022-02-24 |
| 2020-06-30 | $181.40M 10-K · filed 2021-02-26 |
| 2019-06-28 | $50.80M 10-K · filed 2020-03-16 |
| 2018-06-30 | $208.60M 10-K · filed 2019-03-04 |
| 2017-06-30 | $88.30M 10-K · filed 2018-03-13 |
| 2016-06-30 | $126.90M 10-K · filed 2017-03-07 |
| 2015-06-30 | $354.20M 10-K · filed 2016-03-08 |
| 2014-06-30 | $399.10M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |